US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

ProNAi Therapeutics

1.56

-0.0700-4.29%

Volume:428.17K

Turnover:667.94K

Market Cap:47.37M

PE:-0.94

High:1.65

Open:1.63

Low:1.53

Close:1.63

Loading ...

Overview Company News Filings

Company Profile

Company Name:

ProNAi Therapeutics

Exchange:

NASDAQ

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.pronai.com

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

ProNAi Therapeutics, Inc., a clinical-stage oncology company, develops and commercializes drugs based on its DNA interference (DNAi) technology platform for patients with cancer and hematological malignancies. Its lead DNAi product candidate is PNT2258, a proprietary formulation of PNT100, a single-stranded 24-base DNAi oligonucleotide, which is in Phase II clinical trials for the treatment of relapsed or refractory diffuse large B-cell lymphoma; and Richters transformed chronic lymphocytic leukemia. The company was formerly known as Phenome Systems, Inc. and changed its name to ProNAi Therapeutics, Inc. in April 2004. ProNAi Therapeutics, Inc. was founded in 2003 and is headquartered in Vancouver, Canada.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/DNAI/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DNAI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DNAI\",,,,,undefined,":{"symbol":"DNAI","market":"US","secType":"STK","nameCN":"ProNAi Therapeutics","latestPrice":1.56,"timestamp":1483995600000,"preClose":1.63,"halted":4,"volume":428167,"delay":0,"floatShares":20330000,"shares":30366919,"eps":-1.66,"marketStatus":"Delisted","change":-0.07,"latestTime":"01-09 16:00:00 EST","open":1.63,"high":1.65,"low":1.53,"amount":667940.52,"amplitude":0.07362,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.66,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1753171200000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":1.63,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DNAI\",,,,,undefined,":{"symbol":"DNAI","floatShares":20330000,"roa":"--","roe":"--","lyrEps":0,"shares":30366919,"dividePrice":0,"high":1.65,"amplitude":0.07362,"preClose":1.63,"low":1.53,"week52Low":1.32,"pbRate":"--","week52High":12.94,"institutionHeld":0,"latestPrice":1.56,"eps":-1.66,"divideRate":0,"volume":428167,"delay":0,"ttmEps":-1.66,"open":1.63},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.pronai.com","compareEarnings":[{"period":"1week","weight":0.0064},{"period":"1month","weight":0.0504},{"period":"3month","weight":0.1922},{"period":"6month","weight":0.0502},{"period":"1year","weight":0.1356},{"period":"ytd","weight":0.0708}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"ProNAi Therapeutics, Inc., a clinical-stage oncology company, develops and commercializes drugs based on its DNA interference (DNAi) technology platform for patients with cancer and hematological malignancies. Its lead DNAi product candidate is PNT2258, a proprietary formulation of PNT100, a single-stranded 24-base DNAi oligonucleotide, which is in Phase II clinical trials for the treatment of relapsed or refractory diffuse large B-cell lymphoma; and Richters transformed chronic lymphocytic leukemia. The company was formerly known as Phenome Systems, Inc. and changed its name to ProNAi Therapeutics, Inc. in April 2004. ProNAi Therapeutics, Inc. was founded in 2003 and is headquartered in Vancouver, Canada.","exchange":"NASDAQ","name":"ProNAi Therapeutics","nameEN":"ProNAi Therapeutics"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"DNAI\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DNAI\",params:#limit:5,,,undefined,":[{"date":"2017-01-10","symbol":"DNAI","reason":"交易代码变更为SRRA","type":"delisting","dateTimestamp":1484024400000},{"market":"US","date":"2016-11-10","symbol":"DNAI","fiscalQuarterEnding":null,"expectedEps":-0.3,"name":null,"time":"","type":"earning","dateTimestamp":1478754000000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2016-08-12","symbol":"DNAI","fiscalQuarterEnding":null,"expectedEps":-0.38,"name":null,"time":"","type":"earning","dateTimestamp":1470974400000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2016-05-10","symbol":"DNAI","fiscalQuarterEnding":null,"expectedEps":-0.42,"name":null,"time":"","type":"earning","dateTimestamp":1462852800000,"reportTimeType":"","actualEps":-0.35},{"market":"US","date":"2016-03-03","symbol":"DNAI","fiscalQuarterEnding":null,"expectedEps":-0.38,"name":null,"time":"","type":"earning","dateTimestamp":1456981200000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DNAI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DNAI\",market:\"US\",delay:false,,,undefined,":{}}}